Japan, GSK, Novartis Sign Contracts For H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
Japan signed contracts with GlaxoSmithKline and Novartis to supply enough H1N1 flu vaccine to treat nearly 50 million people